臨床研究等提出・公開システム

A Study of Chronic Pain Treatment with Human Mesenchymal Stem Cell Conditioned Medium

A study of treatment of chronic pain with MSC-CM

Sugawara Kou

Sugawara Orthopedic Clinic

9-18 Doyacho, Ichinoseki, Iwate

sugawaraseikei918@outlook.jp

Sugawara Kou

Sugawara Orthopedic Clinic

9-18 Doyacho, Ichinoseki, Iwate

+81-191-23-0501

sugawaraseikei918@outlook.jp

Recruiting

April. 03, 2024

Observational

1. Individuals who is diagnosed having chronic pain.
2. Those for whom satisfactory pain relief effects were not observed with standard therapy.
3. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy for chronic pain due to concerns about side effects, and have been deemed suitable for chronic pain treatment with conditioned medium by a physician.

The patient selection criteria are as follows:
<Inclusion Criteria>
Patients meeting the following criteria will be considered eligible:

1. Individuals aged 18 and above.
2. Individuals with normal decision-making capacity.
3. Individuals who have been provided with the informed consent document regarding this treatment, received sufficient explanation, and can provide voluntary written consent.
4. Individuals for whom the attending physician has recognized the necessity of treatment.

Individuals meeting any of the following conditions will be excluded from the study:
1. Individuals without pain other than nociplastic pain.
2. Patients with a history or suspicion of dementia
3. Users of narcotics or stimulants.
4. Individuals deemed inappropriate by the attending physician.

Both

Chronic Pain

D059350

1. Effect of pain on daily life
2. Pain intensity (Numerical Rating Scale; NRS)
3. Pain area

subjective symptoms, etc.

+81-797-22-5511

Mar. 27, 2024

No

none